182 related articles for article (PubMed ID: 35633161)
1. Human urinary kallidinogenase decreases the incidence of post-stroke cognitive impairment in acute ischemic stroke patients.
Yan X; Chen H; Shang X
J Integr Neurosci; 2022 Apr; 21(3):80. PubMed ID: 35633161
[TBL] [Abstract][Full Text] [Related]
2. Association between serum cystatin C level and post-stroke cognitive impairment in patients with acute mild ischemic stroke.
Yan X; Chen H; Shang XL
Brain Behav; 2022 Mar; 12(3):e2519. PubMed ID: 35148465
[TBL] [Abstract][Full Text] [Related]
3. Human urinary kallindinogenase therapy for acute ischemic stroke according to Chinese ischemic stroke subclassification: Clinical efficacy and risk factors.
Chen SQ; Mao DY; Wei DC; He WZ
Brain Behav; 2020 Jan; 10(1):e01461. PubMed ID: 31793238
[TBL] [Abstract][Full Text] [Related]
4. Human Urinary kallidinogenase promotes good recovery in ischemic stroke patients with level 3 hypertension.
Wu D; Lyu Y; Zhong P; Liu F; Liu X
Brain Behav; 2017 Aug; 7(8):e00752. PubMed ID: 28828213
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Safety of Dl-3-n-Butylphthalide Combined With Human Urinary Kallidinogenase in the Treatment of Acute Ischemic Stroke.
Zhang Y; Zhou F; Li H; Lei J; Mo Z; Li G; Wang J
Clin Neuropharmacol; 2023 Mar-Apr 01; 46(2):60-65. PubMed ID: 36790373
[TBL] [Abstract][Full Text] [Related]
6. Impact of Serum Cystatin C Level on Long-Term Cognitive Impairment After Acute Ischemic Stroke and Transient Ischemic Attack.
Zuo L; Dong Y; Pan Y; Yan H; Meng X; Li H; Zhao X; Wang Y; Wang Y; Liao X
Neuropsychiatr Dis Treat; 2023; 19():1543-1554. PubMed ID: 37435549
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Human Urinary Kallidinogenase for Acute Ischemic Stroke: A Retrospective Single-Center Study.
Wang R; Zhang Y; Shao Y; Yang X; Chen L
Neurologist; 2024 Jan; 29(1):36-40. PubMed ID: 37582684
[TBL] [Abstract][Full Text] [Related]
8. Human urinary kallidinogenase or edaravone combined with butylphthalide in the treatment of acute ischemic stroke.
Qian Y; Lyu Y; Jiang M; Tang B; Nie T; Lu S
Brain Behav; 2019 Dec; 9(12):e01438. PubMed ID: 31638334
[TBL] [Abstract][Full Text] [Related]
9. Effects of Urinary Kallidinogenase on NIHSS score, mRS score, and fasting glucose levels in acute ischemic stroke patients with abnormal glucose metabolism: A prospective cohort study.
Chen L; Geng L; Chen J; Yan Y; Yang L; Zhao J; Sun Q; He J; Bai L; Wang X
Medicine (Baltimore); 2019 Aug; 98(35):e17008. PubMed ID: 31464958
[TBL] [Abstract][Full Text] [Related]
10. Human Urinary Kallidinogenase decreases recurrence risk and promotes good recovery.
Han D; Chen X; Li D; Liu S; Lyu Y; Feng J
Brain Behav; 2018 Aug; 8(8):e01033. PubMed ID: 30030910
[TBL] [Abstract][Full Text] [Related]
11. Human urinary kallidinogenase in acute ischemic stroke: A single-arm, multicenter, phase IV study (RESK study).
Ni J; Yao M; Wang LH; Yu M; Li RH; Zhao LH; Wang JC; Wang YZ; Wang X; Song HQ; Luo BY; Wang JW; Huang YN; Cui LY;
CNS Neurosci Ther; 2021 Dec; 27(12):1493-1503. PubMed ID: 34510762
[TBL] [Abstract][Full Text] [Related]
12. Serum Galectin-3 as a Potential Predictive Biomarker Is Associated with Poststroke Cognitive Impairment.
Wang Q; Wang K; Ma Y; Li S; Xu Y
Oxid Med Cell Longev; 2021; 2021():5827812. PubMed ID: 34900086
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a clinical model (DREAM-LDL) for post-stroke cognitive impairment at 6 months.
Dong Y; Ding M; Cui M; Fang M; Gong L; Xu Z; Zhang Y; Wang X; Xu X; Liu X; Li G; Zhao Y; Dong Q
Aging (Albany NY); 2021 Sep; 13(17):21628-21641. PubMed ID: 34506303
[TBL] [Abstract][Full Text] [Related]
14. Human urinary kallidinogenase in treating acute ischemic stroke patients: analyses of pooled data from a randomized double-blind placebo-controlled phase IIb and phase III clinical trial.
Dong Y; Qu J; Zhang Z; Wang C; Dong Q
Neurol Res; 2020 Apr; 42(4):286-290. PubMed ID: 32138624
[No Abstract] [Full Text] [Related]
15. Persisting cognitive impairment predicts functional dependence at 1 year after stroke and transient ischemic attack: a longitudinal, cohort study.
Liao X; Zuo L; Dong Y; Pan Y; Yan H; Meng X; Li H; Zhao X; Wang Y; Shi J; Wang Y
BMC Geriatr; 2022 Dec; 22(1):1009. PubMed ID: 36585624
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Human Urinary Kallidinogenase Combined with Maixuekang Capsule Promotes Good Functional Outcome in Ischemic Stroke.
Song J; Lyu Y; Wang M; Zhang J; Gao L; Tong X
Front Physiol; 2018; 9():84. PubMed ID: 29487537
[No Abstract] [Full Text] [Related]
17. Lower glomerular filtration rate after mild stroke induces cognitive impairment by causing endothelial dysfunction.
Shang X; Yan X; Chen H
Sci Rep; 2024 Mar; 14(1):6964. PubMed ID: 38521825
[TBL] [Abstract][Full Text] [Related]
18. The association between serum uric acid level and the risk of cognitive impairment after ischemic stroke.
Sun J; Lv X; Gao X; Chen Z; Wei D; Ling Y; Zhang J; Gu Q; Liu J; Chen W; Liu S
Neurosci Lett; 2020 Aug; 734():135098. PubMed ID: 32485287
[TBL] [Abstract][Full Text] [Related]
19. Protective effects of human urinary kallidinogenase against corticospinal tract damage in acute ischemic stroke patients.
Li P; Lu H; Shi X; Yan J; Zhou L; Yang J; Wang B; Zhao Y; Liu L; Zhu Y; Xu L; Yang X; Su X; Yang Y; Zhang T; Guo L; Liu X
Neuroreport; 2024 May; 35(7):431-438. PubMed ID: 38526971
[TBL] [Abstract][Full Text] [Related]
20. Serum TG/HDL-C level at the acute phase of ischemic stroke is associated with post-stroke cognitive impairment.
Cheng Y; Zhu H; Chen J; Li L; Liu C; Gao Y; Sun D
Neurol Sci; 2022 Oct; 43(10):5977-5984. PubMed ID: 35829832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
